{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-061349","form_type":"8-K","ticker":"LPAA","cik":"0002015502","company_name":"Launch One Acquisition Corp.","filed_at":"2024-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.361065+00:00","generated_at":"2026-05-31T20:52:11.246739+00:00","sec_items":["1.01","2.03","3.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Launch One Acquisition Corp. closes $230M IPO, trust funded","bullets":["Closed IPO of 23,000,000 units at $10.00/unit, gross proceeds $230M; includes full over-allotment exercise.","Issued 6M private placement warrants ($1 each) to sponsor (4M) and Cantor (2M), raising $6M; exercisable at $11.50.","Placed $230M of total proceeds into trust; funds released only upon business combination or liquidation within 24 months.","Amended sponsor promissory note: loan limit increased from $300K to $340K, no interest, repayable at IPO closing.","SPAC focus is healthcare/life sciences globally; led by CEO Chris Ehrlich, Chairman Ryan Gilbert, CFO Jurgen van de Vyver."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-061349","json":"https://secwatch.observer/filing/0001213900-24-061349.json","markdown":"https://secwatch.observer/filing/0001213900-24-061349.md","text":"https://secwatch.observer/filing/0001213900-24-061349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2015502/000121390024061349/0001213900-24-061349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2015502/000121390024061349/ea0209363-8k_launch.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:52:11.246739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001193125-26-253506","ticker":"JAGX","company_name":"Jaguar Health, Inc.","filed_at":"2026-06-02T20:10:13+00:00","headline":"Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8","event_type":"other_material","sec_items":["1.01","3.02","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 1.01, 3.02, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253506","json":"https://secwatch.observer/filing/0001193125-26-253506.json","markdown":"https://secwatch.observer/filing/0001193125-26-253506.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/0001193125-26-253506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/d95782d8k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026890","ticker":"XWIN","company_name":"XMax Inc.","filed_at":"2026-06-02T20:30:36+00:00","headline":"XMax raises $3.6M via private placement of 486,500 shares at $7.347/share","event_type":"other_material","sec_items":["1.01","3.02","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 1.01, 3.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026890","json":"https://secwatch.observer/filing/0001493152-26-026890.json","markdown":"https://secwatch.observer/filing/0001493152-26-026890.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1473334/000149315226026890/0001493152-26-026890-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1473334/000149315226026890/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026866","ticker":"OTAI","company_name":"Starlink AI Acquisition Corp","filed_at":"2026-06-02T20:05:25+00:00","headline":"Starlink AI Acquisition closes partial over-allotment, adds $5M to trust","event_type":"other_material","sec_items":["3.02","8.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 3.02, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026866","json":"https://secwatch.observer/filing/0001493152-26-026866.json","markdown":"https://secwatch.observer/filing/0001493152-26-026866.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2094076/000149315226026866/0001493152-26-026866-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2094076/000149315226026866/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251789","ticker":"GIPR","company_name":"GENERATION INCOME PROPERTIES, INC.","filed_at":"2026-06-01T21:27:59+00:00","headline":"Generation Income Properties prices $5.0M public offering of 23.8M shares and warrants at $0.21/unit","event_type":"other_material","sec_items":["1.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 1.01, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251789","json":"https://secwatch.observer/filing/0001193125-26-251789.json","markdown":"https://secwatch.observer/filing/0001193125-26-251789.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651721/000119312526251789/0001193125-26-251789-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651721/000119312526251789/gipr-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001437749-26-019196","ticker":"NRXP","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2026-06-02T21:30:08+00:00","headline":"NRx Pharmaceuticals proposes public offering of common stock; terms not set","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-019196","json":"https://secwatch.observer/filing/0001437749-26-019196.json","markdown":"https://secwatch.observer/filing/0001437749-26-019196.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/0001437749-26-019196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/nrxp20260602_8k.htm"},"side_by_side_evidence":null},{"accession":"0001398344-26-010206","ticker":null,"company_name":"Partners Group Lending Fund, LLC","filed_at":"2026-06-02T21:12:15+00:00","headline":"Partners Group Lending Fund reports April 30 NAV of $1.5013/unit; portfolio $501.1M","event_type":"other_material","sec_items":["3.02","8.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 3.02, 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001398344-26-010206","json":"https://secwatch.observer/filing/0001398344-26-010206.json","markdown":"https://secwatch.observer/filing/0001398344-26-010206.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938649/000139834426010206/0001398344-26-010206-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938649/000139834426010206/fp0099279-1_8kixbrl.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-253795","ticker":"AVA","company_name":"AVISTA CORP","filed_at":"2026-06-02T21:02:55+00:00","headline":"Avista signs non-binding MOU for 125 MW load, expandable to 500 MW by 2032","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253795","json":"https://secwatch.observer/filing/0001193125-26-253795.json","markdown":"https://secwatch.observer/filing/0001193125-26-253795.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/104918/000119312526253795/0001193125-26-253795-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/104918/000119312526253795/ava-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039818","ticker":"ARVN","company_name":"ARVINAS, INC.","filed_at":"2026-06-02T20:39:40+00:00","headline":"Arvinas to out-license ARV-806 after completing Phase 1 dose escalation","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039818","json":"https://secwatch.observer/filing/0001628280-26-039818.json","markdown":"https://secwatch.observer/filing/0001628280-26-039818.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026039818/0001628280-26-039818-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026039818/arvn-20260602.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}